Compare Quest Diagnostics Inc (DGX) vs Redwire Corporation (RDW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs Redwire Corporation — how do they compare? Quest Diagnostics Inc trades at $237.5 (market cap $26.21B), while Redwire Corporation trades at $13.6 (market cap $3.38B). The key difference: Quest Diagnostics Inc is far larger — about 7.8× Redwire Corporation's market cap, and Quest Diagnostics Inc pays a 1.45% dividend while Redwire Corporation pays none. Which is the better fit depends on your goals.
| DGX | RDW | |
|---|---|---|
Market Cap | $26.21B | $3.38B |
Sector | Health | Technology |
52-Week High | $238.50 | $25.90 |
52-Week Low | $173.49 | $5.06 |
Enterprise Value | $31.97B | $2.91B |
Dividend Yield | 1.45% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About Redwire Corporation
Redwire Corporation is a pure-play space infrastructure company that provides a wide range of advanced solutions for the next generation of space exploration and utilization. The company's capabilities span critical space technology, including on-orbit servicing, satellite components, space robotics, and digital engineering. Redwire's products and services are used by civil, commercial, and national security customers to enable missions from low Earth orbit to deep space.
Read more on RDW →
